Cancer prevention videos and webinars related to DCP programs.
-
This webinar will focus on the role of cancer caregivers in promoting symptom management and optimal cancer outcomes. The speakers will discuss the importance of addressing caregivers’ wellbeing during cancer and interventions designed for the patient-caregiver dyad to optimize health and quality
-
In this installment of the Building Bridges in Cancer Symptom Science Webinar Series, the speakers focused on interventions for cancer-related cognitive impairment. Dr. Agnès Lacreuse discussed pharmacological interventions for cognitive decline induced by aromatase-inhibitor therapy in a...
-
Bladder cancer (BC) is one of the most frequently diagnosed neoplasms, with an estimated half a million new cases and 200,000 deaths per year worldwide. Men have a 3-4 times higher risk of developing bladder cancer than women.
-
In this webinar, Dr. Alberti discussed methods for studying chemotherapy-induced peripheral neuropathy (CIPN) in preclinical studies and building collaborative translational teams. Dr. Smith then addressed methods and techniques for assessing CIPN in clinical trials.
-
Dr. Weissman earned his M.D. and Ph.D. in immunology and microbiology in 1987 at Boston University School of Medicine. Dr. Weissman is a physician-scientist and pioneer in the science of immunology.
-
In 2020, cervical cancer resulted in over 600,000 deaths worldwide, despite being largely preventable through vaccination and screening. The disease primarily impacts women in low- and middle-income countries (LMICs), who represent 85% of the cases and 90% of the deaths.
-
In this webinar, Dr. Hinds reviewed advances in the screening and evaluation of fatigue in children and adolescents/young adults during and following cancer treatment. Dr. Kadan-Lottick then addressed the factors that contributed to fatigue, summarized evidence-based approaches to its treatment...
-
Pancreatic ductal adenocarcinoma (PDAC) remains a deadly disease and is projected to be the third leading cause of death by 2030. Contemporary immunotherapies have shown little to now response in PDAC.
-
In this kick-off webinar, Dr. Patricia A. Ganz provided a keynote address on the state of symptom science research.
-
Please join the NCI Division of Cancer Prevention Immunology Interest Group (DCP IIG) seminar series talk focused on cancer prevention, interception, and immuno-oncology.